Fetal Bovine Serum (FBS) is one of the most variable and risk‑sensitive raw materials in cell culture. While many organizations default to US-origin FBS, this preference is often based on history or comfort rather than objective differences in performance or safety.
Premium grade FBS is exclusively collected from government-inspected abattoirs in the United States, Australia, and New Zealand and derived from healthy bovine cows and heifers that have passed ante- and post-mortem inspection. These countries are recognized by the World Organization for Animal Health (WOAH) as having a negligible risk of Bovine Spongiform Encephalopathy (BSE) and being free from Foot and Mouth Disease (FMD).
When properly collected, processed, and qualified, Australian-origin and New Zealand-origin FBS deliver equivalent biological performance and comparable regulatory risk profiles to US-origin FBS for most applications, while offering meaningful supply chain and risk‑diversification advantages.